Welcome Inês Natal, our newest Trainee CQV Engineer.
Inês was born in Cascais and she holds a Master in Applied Microbiology from the Faculty of Sciences and a degree in Biology from the School of Agriculture, both belonging to the University of Lisbon. She had participated in research projects in Academia and worked as a Laboratory Technician in microbiology and molecular biology.
Currently she has been working at Stepscience on the development of pharmaceutical manufacturing plant. This experience is allowing her to gain insight into setting up a pharmaceutical facility, while contributing to a highly regulated and quality-driven environment.
Inês’s first impression of Stepscience was of a dynamic and welcoming environment, with colleagues eager to help and share their knowledge. She has also noticed a strong sense of trust between the employees and a well-structured organization. In Stepscience Inês values the presence of people from diverse backgrounds, as it allows for different perspectives to enrich projects and lead to more innovative solutions. The openness in knowledge-sharing, combined with the trust placed in employees’ skills across various areas of expertise, creates an environment where it’s easy to grow, collaborate, and contribute meaningfully.
She would define herself as an organized, meticulous, and hardworking professional who thrives on learning and exploring new areas. She enjoys applying new knowledge in practice, solving problems creatively, and contributing effectively to team projects.
In her free time Inês enjoys activities that allow her to be creative and relax, such as horse riding, reading, painting, photography, and listening to music and podcasts. She also loves taking long walks with her dog.
Looking ahead, Inês wants to further develop her professional skills and actively contribute to different projects at Stepscience, becoming a trusted colleague in her team.
There is still much to discover in the Pharmaceutical and Life Science Industries, including organisms and their compounds, that could lead to new treatments for various diseases. The future lies in strengthening the bridge between academic research and industry, while making both knowledge and treatments accessible to all.